Manaf AlMatar

580 total citations
27 papers, 415 citations indexed

About

Manaf AlMatar is a scholar working on Molecular Biology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Manaf AlMatar has authored 27 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Infectious Diseases and 6 papers in Molecular Medicine. Recurrent topics in Manaf AlMatar's work include Antibiotic Resistance in Bacteria (6 papers), Tuberculosis Research and Epidemiology (5 papers) and Mycobacterium research and diagnosis (4 papers). Manaf AlMatar is often cited by papers focused on Antibiotic Resistance in Bacteria (6 papers), Tuberculosis Research and Epidemiology (5 papers) and Mycobacterium research and diagnosis (4 papers). Manaf AlMatar collaborates with scholars based in Türkiye, Malaysia and Oman. Manaf AlMatar's co-authors include Fatih Köksal, Essam A. Makky, İşıl Var, Md. Rashedul Islam, Tahira Batool, Ebru Kafkas, Mohamed A. Eldeeb, Aizi Nor Mazila Ramli and Hamza Saghrouchni and has published in prestigious journals such as Pharmacological Research, Biomedicine & Pharmacotherapy and Current Drug Targets.

In The Last Decade

Manaf AlMatar

23 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manaf AlMatar Türkiye 12 157 82 79 53 50 27 415
Didem Kart Türkiye 15 141 0.9× 68 0.8× 39 0.5× 30 0.6× 33 0.7× 41 508
Pankaj Chetia India 10 178 1.1× 107 1.3× 146 1.8× 21 0.4× 30 0.6× 41 536
Ravindran Durgadevi India 15 250 1.6× 65 0.8× 95 1.2× 102 1.9× 54 1.1× 22 570
Shaoqi Qu China 12 213 1.4× 38 0.5× 66 0.8× 23 0.4× 30 0.6× 41 550
Jintae Lee South Korea 10 279 1.8× 149 1.8× 47 0.6× 30 0.6× 34 0.7× 11 527
Areej M. El‐Mahdy Egypt 10 129 0.8× 35 0.4× 83 1.1× 34 0.6× 20 0.4× 13 297
Rosa Giugliano Italy 13 174 1.1× 48 0.6× 42 0.5× 15 0.3× 48 1.0× 30 423
Saswati Sengupta India 7 202 1.3× 33 0.4× 131 1.7× 28 0.5× 33 0.7× 8 517
Wafaa E. Soliman Egypt 15 173 1.1× 32 0.4× 61 0.8× 53 1.0× 24 0.5× 35 582
Pitchaipillai Sankar Ganesh India 11 231 1.5× 39 0.5× 65 0.8× 78 1.5× 20 0.4× 50 509

Countries citing papers authored by Manaf AlMatar

Since Specialization
Citations

This map shows the geographic impact of Manaf AlMatar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manaf AlMatar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manaf AlMatar more than expected).

Fields of papers citing papers by Manaf AlMatar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manaf AlMatar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manaf AlMatar. The network helps show where Manaf AlMatar may publish in the future.

Co-authorship network of co-authors of Manaf AlMatar

This figure shows the co-authorship network connecting the top 25 collaborators of Manaf AlMatar. A scholar is included among the top collaborators of Manaf AlMatar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manaf AlMatar. Manaf AlMatar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
AlMatar, Manaf, et al.. (2025). Transcriptome-Based Analysis of the Oxidative Response of Thermotoga maritima to the O2 Stress. Combinatorial Chemistry & High Throughput Screening. 29(3). 423–437.
3.
AlMatar, Manaf, et al.. (2024). Mutations in Rv0678, Rv2535c, and Rv1979c Confer Resistance to Bedaquiline in Clinical Isolates of Mycobacterium Tuberculosis. Current Molecular Pharmacology. 17. e18761429314641–e18761429314641.
4.
AlMatar, Manaf, et al.. (2024). The Effectiveness of LISTEXTM P100 in Reducing the Biofilm of Listeria spp. on Steel, Plastic, and Galvanised Surfaces. Current Pharmaceutical Biotechnology. 26(4). 539–549.
6.
AlMatar, Manaf, et al.. (2023). Antimicrobial Resistance of Clinical Klebsiella pneumoniae Isolates:Involvement of AcrAB and OqxAB Efflux Pumps. Current Molecular Pharmacology. 17. e310323215266–e310323215266. 9 indexed citations
7.
AlMatar, Manaf, Essam A. Makky, & Aizi Nor Mazila Ramli. (2022). Natural Polysaccharides Alleviate Neurological Disorders: New Updates. Mini-Reviews in Medicinal Chemistry. 22(22). 2813–2819. 4 indexed citations
8.
Makky, Essam A., et al.. (2021). Evaluation of the Antioxidant and Antimicrobial Activities of Ethyl Acetate Extract of Saccharomyces cerevisiae. Food Technology and Biotechnology. 59(2). 127–136. 13 indexed citations
9.
AlMatar, Manaf, et al.. (2020). An Overview of the Activities of Cefiderocol Against Sensitive and Multidrug- Resistant (MDR) Bacteria. Mini-Reviews in Medicinal Chemistry. 20(18). 1908–1916. 2 indexed citations
10.
AlMatar, Manaf, et al.. (2020). A Glance on the Role of Bacterial Siderophore from the Perspectives of Medical and Biotechnological Approaches. Current Drug Targets. 21(13). 1326–1343. 6 indexed citations
11.
AlMatar, Manaf, et al.. (2020). Efflux pump inhibitors: new updates. Pharmacological Reports. 73(1). 1–16. 57 indexed citations
12.
AlMatar, Manaf, et al.. (2018). Does the Development of Vaccines Advance Solutions for Tuberculosis?. Current Molecular Pharmacology. 12(2). 83–104. 1 indexed citations
13.
AlMatar, Manaf, et al.. (2017). The Physiological/Pathophysiological Significance of Vitamin D in Cancer, Cardiovascular Disorders and Beyond. Current Drug Metabolism. 18(3). 207–224. 3 indexed citations
14.
AlMatar, Manaf, et al.. (2017). New drugs for the treatment of Mycobacterium tuberculosis infection. Biomedicine & Pharmacotherapy. 91. 546–558. 31 indexed citations
15.
AlMatar, Manaf, et al.. (2017). Antimicrobial peptides as an alternative to anti-tuberculosis drugs. Pharmacological Research. 128. 288–305. 56 indexed citations
16.
AlMatar, Manaf, et al.. (2017). Pomegranate as a Possible Treatment in Reducing Risk of Developing Wound Healing, Obesity, Neurodegenerative Disorders, and Diabetes Mellitus. Mini-Reviews in Medicinal Chemistry. 18(6). 507–526. 30 indexed citations
17.
AlMatar, Manaf, et al.. (2017). Novel compounds targeting InhA for TB therapy. Pharmacological Reports. 70(2). 217–226. 20 indexed citations
18.
AlMatar, Manaf, et al.. (2016). Are There Any Other Compounds Isolated From Dermacoccus spp at All?. Current Microbiology. 74(1). 132–144. 9 indexed citations
19.
AlMatar, Manaf, Tahira Batool, & Essam A. Makky. (2016). Therapeutic Potential of N-Acetylcysteine for Wound Healing, Acute Bronchiolitis, and Congenital Heart Defects. Current Drug Metabolism. 17(2). 156–167. 12 indexed citations
20.
AlMatar, Manaf & Essam A. Makky. (2015). Cladosporium cladosporioides from the perspectives of medical and biotechnological approaches. 3 Biotech. 6(1). 4–4. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026